Richard Pieris Exports Past Earnings Performance
Past criteria checks 0/6
Richard Pieris Exports has been growing earnings at an average annual rate of 6.1%, while the Chemicals industry saw earnings growing at 30.3% annually. Revenues have been growing at an average rate of 12% per year.
Key information
6.1%
Earnings growth rate
6.1%
EPS growth rate
| Chemicals Industry Growth | 33.7% |
| Revenue growth rate | 12.0% |
| Return on equity | -2.7% |
| Net Margin | -1.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Richard Pieris Exports makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 7,337 | -77 | 1,330 | 0 |
| 30 Sep 23 | 7,156 | -86 | 1,403 | 0 |
| 30 Jun 23 | 7,747 | 96 | 1,566 | 0 |
| 31 Mar 23 | 9,041 | 979 | 1,897 | 0 |
| 31 Dec 22 | 8,942 | 2,035 | 1,879 | 0 |
| 30 Sep 22 | 8,812 | 2,122 | 1,838 | 0 |
| 30 Jun 22 | 7,905 | 1,991 | 1,694 | 0 |
| 31 Mar 22 | 6,537 | 1,299 | 1,353 | 0 |
| 31 Dec 21 | 6,278 | 651 | 1,107 | 0 |
| 30 Sep 21 | 5,985 | 674 | 921 | 0 |
| 30 Jun 21 | 5,887 | 711 | 785 | 0 |
| 31 Mar 21 | 5,362 | 637 | 640 | 0 |
| 31 Dec 20 | 5,007 | 595 | 569 | 0 |
| 30 Sep 20 | 4,947 | 549 | 525 | 0 |
| 30 Jun 20 | 4,821 | 551 | 489 | 0 |
| 31 Mar 20 | 5,212 | 644 | 541 | 0 |
| 31 Dec 19 | 5,505 | 618 | 629 | 0 |
| 30 Sep 19 | 5,421 | 674 | 670 | 0 |
| 30 Jun 19 | 5,221 | 621 | 698 | 0 |
| 31 Mar 19 | 5,182 | 593 | 716 | 0 |
| 31 Dec 18 | 4,895 | 572 | 669 | 0 |
| 30 Sep 18 | 4,693 | 488 | 633 | 0 |
| 30 Jun 18 | 4,436 | 428 | 590 | 0 |
| 31 Mar 18 | 4,272 | 416 | 577 | 0 |
| 31 Dec 17 | 4,183 | 406 | 561 | 0 |
| 30 Sep 17 | 3,976 | 419 | 548 | 0 |
| 30 Jun 17 | 4,003 | 467 | 536 | 0 |
| 31 Mar 17 | 3,818 | 462 | 490 | 0 |
| 31 Dec 16 | 3,636 | 446 | 471 | 0 |
| 30 Sep 16 | 3,427 | 407 | 433 | 0 |
| 30 Jun 16 | 3,181 | 376 | 407 | 0 |
| 31 Mar 16 | 3,048 | 364 | 392 | 0 |
| 31 Dec 15 | 2,907 | 330 | 364 | 0 |
| 30 Sep 15 | 2,771 | 313 | 344 | 0 |
| 30 Jun 15 | 2,604 | 300 | 331 | 0 |
| 31 Mar 15 | 2,498 | 268 | 321 | 0 |
| 31 Dec 14 | 2,443 | 268 | 372 | 0 |
| 30 Sep 14 | 2,422 | 254 | 353 | 0 |
| 30 Jun 14 | 2,427 | 220 | 334 | 0 |
| 31 Mar 14 | 2,394 | 193 | 317 | 0 |
| 31 Dec 13 | 2,345 | 170 | 249 | 0 |
| 30 Sep 13 | 2,301 | 159 | 234 | 0 |
| 30 Jun 13 | 2,303 | 146 | 223 | 0 |
Quality Earnings: REXP.N0000 is currently unprofitable.
Growing Profit Margin: REXP.N0000 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: REXP.N0000 is unprofitable, but has reduced losses over the past 5 years at a rate of 6.1% per year.
Accelerating Growth: Unable to compare REXP.N0000's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: REXP.N0000 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-45.1%).
Return on Equity
High ROE: REXP.N0000 has a negative Return on Equity (-2.67%), as it is currently unprofitable.